Arlington Trust Co LLC Acquires 225 Shares of Dolby Laboratories, Inc. (NYSE:DLB)

Arlington Trust Co LLC lifted its holdings in shares of Dolby Laboratories, Inc. (NYSE:DLB) by 15.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,725 shares of the electronics maker’s stock after acquiring an additional 225 shares during the quarter. Arlington Trust Co LLC’s holdings in Dolby Laboratories were worth $135,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the business. Fifth Third Bancorp boosted its position in Dolby Laboratories by 82.7% during the fourth quarter. Fifth Third Bancorp now owns 360 shares of the electronics maker’s stock worth $28,000 after purchasing an additional 163 shares during the period. Nisa Investment Advisors LLC boosted its holdings in shares of Dolby Laboratories by 436.2% during the 4th quarter. Nisa Investment Advisors LLC now owns 370 shares of the electronics maker’s stock worth $29,000 after buying an additional 301 shares during the period. Mather Group LLC. grew its stake in Dolby Laboratories by 36.8% in the 4th quarter. Mather Group LLC. now owns 528 shares of the electronics maker’s stock valued at $41,000 after buying an additional 142 shares during the last quarter. GAMMA Investing LLC raised its holdings in Dolby Laboratories by 207.5% in the 4th quarter. GAMMA Investing LLC now owns 778 shares of the electronics maker’s stock valued at $61,000 after acquiring an additional 525 shares during the period. Finally, First Horizon Advisors Inc. lifted its position in Dolby Laboratories by 22.7% during the third quarter. First Horizon Advisors Inc. now owns 790 shares of the electronics maker’s stock worth $60,000 after acquiring an additional 146 shares during the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, EVP Mark Andrew Sherman sold 12,338 shares of the company’s stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $78.08, for a total transaction of $963,351.04. Following the completion of the transaction, the executive vice president now directly owns 62,397 shares in the company, valued at approximately $4,871,957.76. This represents a 16.51 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Peter C. Gotcher sold 6,079 shares of the firm’s stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $78.96, for a total value of $479,997.84. Following the sale, the director now directly owns 37,593 shares in the company, valued at approximately $2,968,343.28. This trade represents a 13.92 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 182,917 shares of company stock worth $14,861,429. 38.39% of the stock is currently owned by corporate insiders.

Dolby Laboratories Trading Down 0.7 %

Shares of DLB stock opened at $83.81 on Monday. The stock has a 50 day simple moving average of $79.87 and a 200 day simple moving average of $75.87. Dolby Laboratories, Inc. has a 1 year low of $66.35 and a 1 year high of $89.66. The stock has a market cap of $8.00 billion, a P/E ratio of 30.81 and a beta of 0.98.

Dolby Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, February 19th. Investors of record on Tuesday, February 11th will be given a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.57%. The ex-dividend date of this dividend is Tuesday, February 11th. Dolby Laboratories’s payout ratio is currently 48.53%.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. Rosenblatt Securities reaffirmed a “buy” rating and issued a $100.00 target price on shares of Dolby Laboratories in a research report on Thursday, January 30th. StockNews.com lowered Dolby Laboratories from a “strong-buy” rating to a “buy” rating in a report on Friday, January 31st. Finally, Barrington Research reissued an “outperform” rating and set a $100.00 target price on shares of Dolby Laboratories in a report on Monday, January 27th.

Dolby Laboratories Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.